PharmaEssentia Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
For the six months, sales was TWD 1,229.47 million compared to TWD 184.44 million a year ago. Net loss was TWD 815.56 million compared to TWD 1,223.86 million a year ago. Basic loss per share from continuing operations was TWD 2.93 compared to TWD 4.71 a year ago.